Status:
COMPLETED
Current Therapy in Primary Sjogren's Syndrome
Lead Sponsor:
Pamukkale University
Conditions:
Primary Sjögren's Syndrome (pSS)
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
Purpose:The aim of the study was to investigate the effectiveness of interferential current therapy on salivary gland function in Primary Sjogren's Syndrome (pSS). Methods:Thirty six pSS were include...
Eligibility Criteria
Inclusion
- To be diagnosed with pSS according to the 2016 European League Against Rheumatism American / College of Rheumatology Classification Criteria,
- To be in the 3rd and 4th grade according to the Chisholm-Mason Grading System,
- be in the age range of 25-65 years,
- To be stable on drug use for at least 3 months or longer, (f) To have agreed to participate in the study.
Exclusion
- To use antipsychotic, antidepressant, antihypertensive, medical agent for Parkinson's,
- Presence of viral infection,
- Presence of Diabetes Mellitus,
- Receiving head and neck radiotherapy/chemotherapy,
- Having a head and neck malignancy,
- Having undergone head and neck surgery,
- Presence of dehydration,
- Pregnancy,
- Using cigarettes and alcohol,
- Cognitive problems that affect cooperation,
- having any other disease that may affect their functions.
Key Trial Info
Start Date :
January 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06989411
Start Date
January 14 2019
End Date
October 5 2023
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Usak University
Uşak, None Selected, Turkey (Türkiye), 64200